Chemical Structure (Image 01)
Movantik
Product Images NDC 57841-1300
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Movantik (NDC 57841-1300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redhill Biopharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Image 02)
Movantik 12.5 mg 30 Tablet Bottle Label (Image 04)
This appears to be a package of medication manufactured by RedHill Biopharma. The dosage information is not provided and is directed to the package insert for further information. It also includes information on storing the medication at a controlled temperature range and asks to keep it out of reach of children. The text also includes information regarding the manufacturer and the GTIN (Global Trade Item Number) barcode.*
Movantik 25 mg 30 Tablet Bottle Label (Image 05)
This is a medicine label that provides dosage instructions and storage details. The recommended dosage is not specified and requires reference to the package insert. It should be stored at room temperature between 20-25°C, with a permissible range of 15-30°C. The medicine is manufactured by AstraZeneca AB in Sweden for RedHill Biopharma Inc. No further information is provided.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
